631PNeoadjuvant therapy for esophageal adenocarcinoma: A propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy. (23rd October 2018) - Barbour, A P; Brosda, S; Wijnhoven, B; van Hootgem, S; Lanschot, J J B; Barbour, S; Lagarde, S; Krause, L; Pryor, D; Thomas, J; Walpole, E T; van der Gaast, A; et al.